NCT03496467View on ClinicalTrials.gov

Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

March 5, 2018

Primary Completion Date

December 17, 2018

Study Completion Date

December 17, 2018

Conditions
PainInflammation
Interventions
COMBINATION_PRODUCT

Nepafenac PPDS

A punctal plug delivery system (PPDS) is being developed as a device that can deliver a sustained release of a drug to a specific eye. The PPDS is made up of a medical grade silicone punctal plug which holds an insert (core) that contains nepafenac, a nonsteroidal anti-inflammatory drug.

COMBINATION_PRODUCT

Placebo PPDS

A punctal plug delivery system (PPDS) is being developed as a device that can deliver a sustained release of a drug to a specific eye. The PPDS is made up of a medical grade silicone punctal plug which holds an insert (core) that does not contain nepafenac.

Trial Locations (3)

11530

Ophthalmic Consultants of Long Island, Garden City

29464

Kerry Solomon, MD, Mt. Pleasant

41017

Cincinnati Eye Institute-Edgewood, Edgewood

Sponsors
All Listed Sponsors
lead

Mati Therapeutics Inc.

INDUSTRY

NCT03496467 - Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract | Biotech Hunter | Biotech Hunter